Epidemiology of pneumonia in hospitalized adults ≥18 years old in four districts of Ulaanbaatar, Mongolia, 2015-2019
- PMID: 36419739
- PMCID: PMC9677069
- DOI: 10.1016/j.lanwpc.2022.100591
Epidemiology of pneumonia in hospitalized adults ≥18 years old in four districts of Ulaanbaatar, Mongolia, 2015-2019
Abstract
Background: Community-acquired pneumonia is a leading cause of morbidity and mortality among children and adults worldwide. Adult pneumonia surveillance remains limited in many low- and middle-income settings, resulting in the disease burden being largely unknown.
Methods: A retrospective cohort study was conducted by reviewing medical charts for respiratory admissions at four district hospitals in Ulaanbaatar during January 2015-February 2019. Characteristics of community-acquired pneumonia cases were summarized by disease severity and age. To explore factors associated with severe pneumonia, we ran univariable and age-adjusted logistic regression models. Incidence rates were calculated using population denominators.
Results: In total, 4290 respiratory admissions met the case definition for clinical pneumonia, including 430 admissions of severe pneumonia. The highest proportion of severe pneumonia admissions occurred in adults >65 years (37.4%). After adjusting for age, there were increased odds of severe pneumonia in males (adjusted odds ratio [aOR]: 1.63; 95% confidence interval [CI]: 1.33-2.00) and those with ≥1 underlying medical condition (aOR: 1.46; 95% CI: 1.14-1.87). The incidence of hospitalized pneumonia in adults ≥18 years increased from 13.49 (95% CI: 12.58-14.44) in 2015 to 17.65 (95% CI: 16.63-18.71) in 2018 per 10,000 population. The incidence of severe pneumonia was highest in adults >65 years, ranging from 9.29 (95% CI: 6.17-13.43) in 2015 to 12.69 (95% CI: 9.22-17.04) in 2018 per 10,000 population.
Interpretations: Vaccination and other strategies to reduce the risk of pneumonia, particularly among older adults and those with underlying medical conditions, should be prioritized.
Funding: Pfizer clinical research collaboration agreement (contract number: WI236621).
Keywords: Adult pneumonia; Disease incidence; Hospitalization; Mongolia; Pneumonia.
© 2022 The Author(s).
Conflict of interest statement
EKM and CVM are lead investigators of this study through Murdoch Childrens Research Institute, which was funded by Pfizer. MU, CDN, BS, DL, BP and TM are investigators on this collaborative research project funded by Pfizer. BDG and EMD are employees of Pfizer and own Pfizer stock or stock options. The other authors have no relevant conflicts of interest to declare. This study is a Murdoch Childrens Research Institute-sponsored study which is investigator-led, and funded under a collaborative agreement by Pfizer Inc.
Figures
References
-
- World Health Organization Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper–February 2019. Weekly Epidemiol Record. 2019;94(8):85–103.
-
- Aston SJ. Pneumonia in the developing world: characteristic features and approach to management. Respirology. 2017;22(7):1276–1287. - PubMed
-
- Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis. 2004;4(2):112–124. - PubMed
-
- Tantawichien T, Hsu LY, Zaidi O, et al. Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas. Expert Rev Vaccines. 2022;21(2):215–226. - PubMed
-
- Almirall J, Serra-Prat M, Bolibar I, Balasso V. Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration. 2017;94(3):299–311. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
